Innovent Biologics Forecast, price target & analysts
Innovent Biologics Target price 2025 - Analyst rating & recommendation
Innovent Biologics Classifications & Recommendation:
Innovent Biologics Price Target
| Target Price | HKD67.22 |
| Price | HKD77.35 |
| Deviation |
13.10%
register free of charge
|
| Number of Estimates | 28 |
|
28 Analysts have issued a price target Innovent Biologics 2026 .
The average Innovent Biologics target price is HKD67.22.
This is
13.10%
register free of charge
HKD99.75
28.96%
register free of charge
HKD38.38
50.38%
register free of charge
|
|
| A rating was issued by 32 analysts: 29 Analysts recommend Innovent Biologics to buy, 2 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Innovent Biologics stock has an average upside potential 2026 of
13.10%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion HKD | 10.31 | 12.93 |
| 51.82% | 25.37% | |
| EBITDA Margin | 3.95% | 6.68% |
| 122.54% | 68.91% | |
| Net Margin | -1.00% | 3.06% |
| 93.94% | 404.66% |
30 Analysts have issued a sales forecast Innovent Biologics 2025 . The average Innovent Biologics sales estimate is
This results in the following potential growth metrics:
24 Analysts have issued an Innovent Biologics EBITDA forecast 2025. The average Innovent Biologics EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
29 Innovent Biologics Analysts have issued a net profit forecast 2025. The average Innovent Biologics net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share HKD | -0.06 | 0.24 |
| 91.67% | 500.00% | |
| P/E | 320.79 | |
| EV/Sales | 9.63 |
29 Analysts have issued a Innovent Biologics forecast for earnings per share. The average Innovent Biologics EPS is
This results in the following potential growth metrics and future valuations:
Innovent Biologics...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
